Large-scale testing (Phase 3)Active Not RecruitingNCT02477696
What this trial is testing
Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)
Who this might be right for
Chronic Lymphocytic Leukemia
Acerta Pharma BV 533